|
1
|
Gregoriou G, Bakas P, Vitoratos N,
Papadias K, Goumas K, Chryssicopoulos A and Creatsas G: Evaluation
serum prolactin levels in patients with endometriosis and
infertility. Gynecol Obstet Invest. 48:48–51. 1999. View Article : Google Scholar
|
|
2
|
Panidis D, Vavilis D, Rousso D, Panidou E
and Kalogeropoulos A: Provocative tests of prolactin before, during
and after long-term danazol treatment in patients with
endometriosis. Gynecol Endocrinol. 6:19–24. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang H, Gorpudolo N and Behr B: The role
of prolactin- and endometriosis-associated infertility. Obstet
Gynecol Surv. 64:542–547. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reese J, Binart N, Brown N, Ma WG, Paria
BC, Das SK, Kelly PA and Dey SK: Implantation and decidualization
defects in prolactin receptor (PRLR)-deficient mice are mediated by
ovarian but not uterine PRLR. Endocrinology. 141:1872–1881.
2000.PubMed/NCBI
|
|
5
|
Novella-Maestre E, Carda C, Noguera I,
Ruiz-Saurí A, García-Velasco JA, Simón C and Pellicer A: Dopamine
agonist administration causes a reduction in endometrial implants
through modulation of angiogenesis in experimentally induced
endometriosis. Hum Reprod. 24:1025–1035. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ben-Jonathan N, LaPensee CR and LaPensee
EW: What can we learn from rodents about prolactin in humans?
Endocr Rev. 29:1–41. 2008. View Article : Google Scholar
|
|
7
|
Missale C, Nash SR, Robinson SW, Jaber M
and Caron MG: Dopamine receptors: From structure to function.
Physiol Rev. 78:189–225. 1998.PubMed/NCBI
|
|
8
|
Nilsson C and Eriksson E: Partial dopamine
D2 receptor agonists antagonize prolactin-regulating D2 receptors
in a transfected clonal cell line (GH4ZR7). Eur J Pharmacol.
218:205–211. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Calarge CA, Ellingrod VL, Acion L, Miller
DD, Moline J, Tansey MJ and Schlechte JA: Variants of the dopamine
D2 receptor gene and risperidone-induced hyperprolactinemia in
children and adolescents. Pharmacogenet Genomics. 19:373–382. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hansen KA, Zhang Y, Colver R, Tho SP,
Plouffe L Jr and McDonough PG: The dopamine receptor D2 genotype is
associated with hyperprolactinemia. Fertil Steril. 84:711–718.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bilibio JP, Matte U, de Conto E, Genro VK,
Souza CA and Cunha-Filho JS: Dopamine receptor D2 genotype (3438)
is associated with moderate/severe endometriosis in infertile women
in Brazil. Fertil Steril. 99:1340–1345. 2013. View Article : Google Scholar
|
|
12
|
Canis M, Donnez JG, Guzick DS, Halme JK,
Rock JA, Schenken RS and Vernon MW: Revised American Society for
Reproductive Medicine classification of endometriosis: 1996. Fertil
Steril. 67:817–821. 1997. View Article : Google Scholar
|
|
13
|
Sasieni PD: From genotypes to genes:
Doubling the sample size. Biometrics. 53:1253–1261. 1997.
View Article : Google Scholar
|
|
14
|
Comings DE and Blum K: Reward deficiency
syndrome: Genetic aspects of behavioral disorders. Prog Brain Res.
126:325–341. 2000.PubMed/NCBI
|
|
15
|
Noble EP: D2 dopamine receptor gene in
psychiatric and neurologic disorders and its phenotypes. Am J Med
Genet B Neuropsychiatr Genet. 116B:103–125. 2003. View Article : Google Scholar
|
|
16
|
Caccavelli L, Cussac D, Pellegrini I,
Audinot V, Jaquet P and Enjalbert A: D2 dopaminergic receptors:
Normal and abnormal transduction mechanisms. Horm Res. 38:78–83.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thompson J, Thomas N, Singleton A, Piggott
M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN and Court JA:
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: Reduced
dopamine D2 receptor binding in the human striatum associated with
the A1 allele. Pharmacogenetics. 7:479–484. 1997. View Article : Google Scholar
|
|
18
|
Noble EP, Blum K, Ritchie T, Montgomery A
and Sheridan PJ: Allelic association of the D2 dopamine receptor
gene with receptor-binding characteristics in alcoholism. Arch Gen
Psychiatry. 48:648–654. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Young RM, Lawford BR, Barnes M, Burton SC,
Ritchie T, Ward WK and Noble EP: Prolactin levels in antipsychotic
treatment of patients with schizophrenia carrying the DRD2*A1
allele. Br J Psychiatry. 185:147–151. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mihara K, Suzuki A, Kondo T,
Yasui-Furukori N, Ono S, Otani K, Kaneko S and Inoue Y:
Relationship between Taq1 A dopamine D2 receptor (DRD2)
polymorphism and prolactin response to bromperidol. Am J Med Genet.
105:271–274. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aklillu E, Kalow W, Endrenyi L, Harper P,
Miura J and Ozdemir V: CYP2D6 and DRD2 genes differentially impact
pharmacodynamic sensitivity and time course of prolactin response
to perphenazine. Pharmacogenet Genomics. 17:989–993. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
López-Rodríguez R, Román M, Novalbos J,
Pelegrina ML, Ochoa D and Abad-Santos F: DRD2 Taq1A polymorphism
modulates prolactin secretion induced by atypical antipsy-chotics
in healthy volunteers. J Clin Psychopharmacol. 31:555–562. 2011.
View Article : Google Scholar
|
|
23
|
Houston JP, Fijal B, Heinloth AN and Adams
DH: Genetic associations of prolactin increase in
olanzapine/fluoxetine combination-treated patients. Psychiatry Res.
175:171–172. 2010. View Article : Google Scholar
|
|
24
|
Houston J, Dharia S, Bishop JR, Ellingrod
VL, Fijal B, Jacobson JG and Hoffmann VP: Association of DRD2 and
ANKK1 polymorphisms with prolactin increase in olanzapine-treated
women. Psychiatry Res. 187:74–79. 2011. View Article : Google Scholar
|
